2:1 (or international equivalent) in an appropriate subject; candidates are generally required to submit a research proposal with their applications.
Months of entry
January, December, November, October, September, August, July, June, May, April, March, February
The clinical interests of the Division are in the treatment of acute stroke, enhancing recovery and preventing recurrence. The following multicentre trials are coordinated by Philip Bath & Niki Sprigg from the Stroke Trials Unit:
- Ultra-acute lowering of blood pressure before hospitalisation (RIGHT trial)
- Hyperacute cooling/hypothermia (EU FP-7 trial)
- Hyperacute tranexamic acid for primary intracerebral haemorrhage (HTA TICH-2 trial)
- Acute lowering of BP in hospital (MRC ENOS trial of glyceryl trinitrate)
- Acute intensive antiplatelets for preventing early recurrence (BHF-HTA TARDIS trial)
- Prevention of post stroke cognitive impairment (TSA-AS PODCAST trial)
- Chronic mobilisation of endogenous stem cells (RfPB STEMS-3 trial of granulocyte colony stimulating factor)
- Research projects are available in each of these studies. The Division of Stroke Medicine hosts the mid Trent part of the UK Stroke Research Network.
The translational studies, led by Dr Ulvi Bayraktutan, aim to identify a series of novel therapeutic targets that can subsequently be employed in clinical settings to prevent and/or reverse ischaemic injury-mediated breakdown of the blood-brain barrier and the ensuing formation of brain oedema which accounts for the majority of deaths within the first week after an ischaemic stroke. In this regard, the currently ongoing projects focus on
- Pro-inflammatory cytokines, notably TNF-alpha and Interleukin-1beta,
- NADPH oxidase enzyme system and oxidative stress,
- Matrix metalloproteinases,
- Plasminogen-plasmin system components,
For a more extensive overview, please visit the course page on the University of Nottingham's online prospectus.
Causes of stroke. Acute treatment of patients after stroke. Prevention of recurrence stroke. Key words: Pathophysiology: Acute management: Recovery and rehabilitation.
Information for international students
English language requirements: IELTS 6.5 (no less than 6.0 in any element).
Fees and funding
The Graduate School at The University of Nottingham provides information on internal and external sources of postgraduate funding.
There is also funding information on the Medical School web pages.
For information on funding opportunities for international students, please see the International Office website.
Qualification and course duration
Further details of qualification
Available in FT and PT modes.
Course contact details
- Postgraduate Enquiries
- +44 (0)115 951 5559